Additionally, the identification of key pathways, including PI3K-Akt signaling and ECM-receptor interactions, which are critical for tumor growth, metastasis, and immune evasion, highlights mechanisms that could be targeted therapeutically [62]. This evidence concerns the gene AKT1 and neoplasm.